Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05857774
Other study ID # 22-5875
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 27, 2023
Est. completion date June 30, 2026

Study information

Verified date May 2024
Source University Health Network, Toronto
Contact Rongyu (Cindy) Jin
Phone 4163404800
Email rongyu.jin@uhn.ca
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Air is normally pumped in and out of the lungs by the muscles that contribute to inhalation and exhalation, called the respiratory muscles. The abdominal muscles help by forcing air out of your lungs during exhalation; whereas the diaphragm, the main muscle used for breathing, contracts to get air into the lungs during inhalation. With mechanical ventilation, respiratory muscles are able to rest and recover while the breathing machine takes over; however, this may cause respiratory muscle weakness. Patients who develop weakness of these muscles may require more assistance from the ventilator and take longer to recover their ability to breathe without assistance. The impact of this phenomenon on long-term outcomes is uncertain. The RESPIRE study is designed to characterize how respiratory muscles change during mechanical ventilation and to evaluate the impact on long term quality of life. An additional objective of this study is to examine novel measures obtained from automated functions of a ventilator, that may better predict success from weaning from mechanical ventilation.


Description:

Previous work has established that diaphragm atrophy during mechanical ventilation is associated with adverse clinical outcomes. Abdominal muscles, which are engaged during breathing also undergo atrophy during mechanical ventilation. However, the relationship between these muscles and how they relate to long term function status is known and warrants further investigation. Mechanical ventilation is a life-saving technique in patients with respiratory failure, however reasons why some patients require long term ventilation and are unsuccessful from weaning from ventilators are not fully elucidated. Respiratory muscle dysfunction as a result of mechanical ventilation is only recently being understood. Diaphragm atrophy is associated with adverse clinical outcomes, but the same is unknown if this holds true with abdominal muscle atrophy. Properly understanding the natural progression of diaphragm and abdominal muscle atrophy and dysfunction, and how they relate to each other, is critical to identifying markers or factors that may put particular patients at risk for long durations of mechanical ventilation and adverse clinical outcomes. This study will provide important insights into the relationship between inspiratory and expiratory muscle function, and the evolution of functional impairments in critical care patients undergoing weaning from invasive mechanical ventilation. Further understanding of the pathophysiological processes of how these muscle groups interact in this context is important in moving forward with potential therapeutic strategies aimed at mitigating injury.


Recruitment information / eligibility

Status Recruiting
Enrollment 230
Est. completion date June 30, 2026
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Cases Inclusion Criteria: • Adult patients =18 years of age undergoing invasive mechanical ventilation in the ICU for any reason within 36 hours of intubation Control condition A Inclusion Criteria: • Non-invasively ventilated patients in the ICU within 36 hours of initiating non-invasive ventilation Control condition B Inclusion Criteria • Non-ventilated patients admitted to the ICU receiving no respiratory support or oxygen therapy alone, including high flow nasal cannula Exclusion Criteria: - Patients expected to be extubated within 24 hours of screening for eligibility - Patients who have already undergone a SBT at time of screening - Patients with a previously diagnosed neuromuscular disorder - Patients receiving long-term invasive mechanical ventilation (prior to current hospitalization) - Patients who have required previously (during current hospitalization) a period of invasive ventilation in ICU of more than 24 hours - Patients who have previously been enrolled in the study - Patients for whom post-hospital follow-up may be challenging, e.g. those who reside overseas or who have no fixed address

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Sonographic measurements
Diaphragm thickness, diaphragm tidal thickening fraction, abdominal muscle thickness, rectus femoris cross-sectional area, maximal diaphragm thickening fraction, abdominal muscle thickening fraction
Physiological measurements
Airway occlusion pressure, maximal inspiratory pressure, muscle research council score
Biological measurements
Skeletal troponin-I

Locations

Country Name City State
Canada Toronto General Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of life at home 5-level EQ-5D (EQ-5D-5L) score - The EQ-5D-5L is a validated self-reported instrument assessing quality of life at the moment questionnaire is completed. Each question is scored from 1 (no problems) to 5 (inability to perform activity) and are independently assessed. Day 180
Primary Quality of life at home Montreal Cognitive Assessment (MOCA) score - MoCA is a clinician-reported measure to assess for cognitive impairments. MoCA is scored out of 30 with scores <26 indicating cognitive impairment. Day 180
Secondary Duration of ventilation Until hospital discharge (up to 6 months)
Secondary Muscle research council score Muscle research council score, is a validated measure of muscle strength. Possible scores range from 0 (complete paralysis) to 60 (normal strength). Assessments will be made at first spontaneous breathing trial & at day 14. Until day 14
Secondary Airway occlusion pressure (P0.1) P0.1 will be assessed during spontaneous breathing trial. Spontaneous breathing trials (SBT) are standard of care to assess if patients are able to be extubated from mechanical ventilation. A specific time frame cannot be provided as SBT are only conducted when care team deem the patient as capable. First spontaneous breathing trial (within 5 minutes of onset)
Secondary Expiratory occlusion pressure (Pocc) Pocc will be assessed during spontaneous breathing trial. Spontaneous breathing trials (SBT) are standard of care to assess if patients are able to be extubated from mechanical ventilation. A specific time frame cannot be provided as SBT are only conducted when care team deem the patient as capable. First spontaneous breathing trial (within 5 minutes of onset)
Secondary Maximal inspiratory pressure (MIP) MIP will be assessed during spontaneous breathing trial. Spontaneous breathing trials (SBT) are standard of care to assess if patients are able to be extubated from mechanical ventilation. A specific time frame cannot be provided as SBT are only conducted when care team deem the patient as capable. First spontaneous breathing trial within 30 minutes of onset
Secondary Days alive and at home at 180 days post ICU discharge Day 180
Secondary Changes in abdominal muscle thickening fraction during cough Abdominal muscle thickening fraction during cough will be assessed by ultrasound during SBT when care team deems patient capable and safe to do so, as such a specific time frame for SBT cannot be provided. Additionally abdominal muscle thickening fraction will be assessed at ICU discharge. A specific time frame cannot be provided as ICU discharge will vary between patients. At first spontaneous breathing trial within 30 minutes of onset and at ICU discharge, an average of 7 days
Secondary Maximal diaphragm thickening fraction Maximal diaphragm thickening fraction will be assessed by ultrasound during SBT when care team deems patient capable and safe to do so, as such a specific time frame for SBT cannot be provided. Additionally abdominal muscle thickening fraction will be assessed at ICU discharge. A specific time frame cannot be provided as ICU discharge will vary between patients. At first spontaneous breathing trial within 30 minutes of onset and at ICU discharge, an average of 7 days
Secondary Changes in resting abdominal muscle thickening Diaphragm ultrasound to measure thickening of abdominal muscles during resting tidal breathing. Until Day 14
Secondary Changes in resting thickening fraction Diaphragm ultrasound to measure thickening fraction during resting tidal breathing. Until Day 14
See also
  Status Clinical Trial Phase
Recruiting NCT05904652 - High Flow Nasal Oxygen at Extubation for Adults Requiring a Breathing Tube for Treating Severe Breathing Difficulties N/A
Completed NCT04030208 - Evaluating Safety and Efficacy of Umbulizer in Patients Requiring Intermittent Positive Pressure Ventilation N/A
Recruiting NCT03697785 - Weaning Algorithm for Mechanical VEntilation N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT02930525 - Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation N/A
Recruiting NCT02539732 - Prediction of Outcome of Weaning From Mechanical Ventilation Using the Electrical Activity of the Diaphragm
Enrolling by invitation NCT02290236 - Monitored Saturation Post-ICU N/A
Completed NCT02056119 - RCT of Mesh Versus Jet Nebulizers on Clinical Outcomes During Mechanical Ventilation in the Intensive Care Unit N/A
Terminated NCT01583088 - Early Stage Amyotrophic Lateral Sclerosis Phrenic Stimulation Phase 3
Withdrawn NCT00990119 - High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD) N/A
Completed NCT01411722 - Electrical Activity of the Diaphragm During the Weaning Period Phase 2
Completed NCT00741949 - Broncho-alveolar Lavage Under Noninvasive Ventilation With Propofol TCI in Patient With AHRF Phase 3
Recruiting NCT00339053 - Immunonutrition and Thoracoabdominal Aorta Aneurysm Repair Phase 4
Recruiting NCT00187434 - Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP) N/A
Completed NCT02687802 - Respiratory Mechanics and Patient-ventilator Asynchrony Index in Patients With Invasive Mechanical Ventilation
Not yet recruiting NCT05906030 - Diaphragm Dysfunction and Ultrasound Perioperatively
Completed NCT03850977 - Is There an Association Between Chronic Pancreatitis and Pulmonary Function
Completed NCT02845375 - Effect of Neuromuscular Blockade and Reversal on Breathing Phase 4
Recruiting NCT03309423 - Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU? N/A
Completed NCT04115969 - Outcome After Non-invasive Ventilation.